Tania Jain

Assistant Professor

20122019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Tania Jain is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles
Stem Cell Transplantation Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences
Primary Myelofibrosis Medicine & Life Sciences
Antigen Receptors Medicine & Life Sciences
Cell- and Tissue-Based Therapy Medicine & Life Sciences
Hematopoietic Stem Cell Transplantation Medicine & Life Sciences
Meta-Analysis Medicine & Life Sciences
Melphalan Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2012 2019

Choosing a Reduced-Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation, Fludarabine/Busulfan versus Fludarabine Melphalan: A Systematic Review and Meta-Analysis

Jain, T., Alahdab, F., Firwana, B., Sonbol, M. B., Almader-Douglas, D. & Palmer, J., Apr 1 2019, In : Biology of Blood and Marrow Transplantation. 25, 4, p. 728-733 6 p.

Research output: Contribution to journalArticle

Busulfan
Melphalan
Stem Cell Transplantation
Meta-Analysis
Confidence Intervals

Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis

Jain, T., Kunze, K. L., Temkit, M., Partain, D. K., Patnaik, M. S., Slack, J. L., Khera, N., Hogan, W. J., Roy, V., Noel, P., Leis, J. F., Sproat, L. Z., Fauble, V., Mesa, R. A. & Palmer, J., Feb 1 2019, In : Bone marrow transplantation. 54, 2, p. 204-211 8 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Hematopoietic Stem Cell Transplantation
Melphalan
Busulfan
Chimerism

Early fluctuations in busulfan levels with therapeutic dose monitoring during allogeneic stem cell transplantation: do they matter?

Jain, T., Kunze, K. L., Khetarpal, B. K., McCallen, M. R., Betcher, J. A., Ofori, H. T., Khera, N., Slack, J. L., Leis, J. F., Sproat, L. Z., Noel, P. & Palmer, J., Jul 3 2019, In : Leukemia and Lymphoma. 60, 8, p. 2034-2041 8 p.

Research output: Contribution to journalArticle

Busulfan
Stem Cell Transplantation
Area Under Curve
Hepatic Veno-Occlusive Disease
Therapeutics
Stem Cell Transplantation
Multiple Myeloma
Meta-Analysis
Transplantation
Drug Therapy

Monoclonal antibody utilization characteristics in patients with multiple myeloma

Ailawadhi, S., Sher, T., Azzouqa, A. G., Meghji, Z., Jain, T., Jani, P., Ahmed, S., Diehl, N., Roy, V., Shah, V., Hodge, D., Ailawadhi, M., Alegria, V. R., Paulus, A., Chanan-Khan, A. & Fonseca, R., Sep 1 2019, In : Anti-cancer drugs. 30, 8, p. 859-865 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Monoclonal Antibodies
Premedication
Clinical Trials
Drug Utilization